Cellular Vehicles


Developer of a standardized, closed, automated platform for final formulation and last-mile dose preparation of advanced therapies (cell & gene, tissue engineering, radiopharma). The platform combines robotics, microfluidic single-use chips, and in-line AI quality control with configurable software protocols and disposable kits to enable therapy-specific, point-of-care compounding and dose preparation.

Industries

Manufacturing
Medical Device
Product Design
Medical Equipment Manufacturing

Nr. of Employees

small (1-50)

Cellular Vehicles

San Mateo, California, United States


Patents

Cellular therapy infusion devices, systems, and methods for use

US-12357772-B2

View Details

Cellular therapy infusion devices, systems, and methods for use

US-11504485-B1

View Details

Products

Closed-system automated formulation and compounding instrument

A standardized, closed, automated, small-footprint instrument that performs final formulation, mixing, and dose dispensing using programmable software protocols and single-use microfluidic kits.

Odyssey System

An automation platform developed to simplify last mile Cell and Gene Therapy handling, preparation, and administration, introducing standardization and lowering costs.


Services

Collaborative development of therapy-specific software protocols and disposable kit designs with biopharma, CDMOs, and academic medical centers to enable automated formulation and dose preparation.

Expertise Areas

  • Advanced therapy final formulation and compounding
  • Point-of-care dose preparation for cell & gene therapies
  • Lab automation and robotics
  • Microfluidics development for disposable chips
  • Show More (4)

Key Technologies

  • Microfluidics
  • Automated liquid handling
  • Robotics for aseptic processes
  • AI-driven inline quality control
  • Show More (3)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.